Revisión crítica de los resultados del ISAAC para dermatitis atópica en ciudades del trópico.

Jorge Sánchez, Andres Sánchez, Ricardo Cardona

Resumen


Existe una creciente preocupación por el notable aumento en la prevalencia de la dermatitis atópica en muchos análisis epidemiológicos, especialmente aquellos realizados en la región del trópico. El estudio internacional más extendido que evalúa la epidemiología de la dermatitis es el estudio ISAAC, que examinó la prevalencia de las enfermedades atópicas más prevalentes en la infancia en casi 200 centros en más de 50 países del mundo. De acuerdo a este estudio, la prevalencia de dermatitis en países tropicales, especialmente de América Latina, fue mayor en comparación con otras regiones, con una moda de 15%. Esta mayor prevalencia entre poblaciones que utilizan la misma encuesta sugiere que algunos factores genéticos y ambientales tienen un efecto importante en el desarrollo de la dermatitis. Sin embargo, teniendo en cuenta que las encuestas fueron completadas por los participantes, otras explicaciones como sesgo y la identificación errónea de la enfermedad por el paciente, son posibles por lo que es necesario realizar estudios comparativos con los estudios de cohorte de la región para determinar si son clínicamente relevantes o no. En este artículo comparamos la prevalencia de dermatitis reportada por el estudio ISAAC en países tropicales y algunos estudios utilizando otros realizados en la región. 


Palabras clave


Atopia; Dermatitis; eczema; epidemiología; America latina; zona tropical.

Referencias


REFERENCES

Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, Group IPTS. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124(6):1251-8.e23. http://dx.doi: 10.1016/j.jaci.2009.10.009.

Sá DC, Festa C. Inflammasomes and dermatology. An Bras Dermatol. 2016;91(5):566-78. http://dx.oi: 10.1590/abd1806-4841.20165577.

Sánchez J, Sánchez A, Cardona R. [Economic consequences in real life of allergen immunotherapy in asthma, rhinitis and dermatitis]. Rev Alerg Mex. 2016;63(4):323-33.

Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol. 2010;105(2):99-106; quiz 7-9, 17.

Genuneit J, Braig S, Brandt S, Wabitsch M, Florath I, Brenner H, et al. Infant atopic eczema and subsequent attention-deficit/hyperactivity disorder--a prospective birth cohort study. Pediatr Allergy Immunol. 2014;25(1):51-6. http://dx.doi: 10.1111/pai.12152.

Grize L, Gassner M, Wüthrich B, Bringolf-Isler B, Takken-Sahli K, Sennhauser FH, et al. Trends in prevalence of asthma, allergic rhinitis and atopic dermatitis in 5-7-year old Swiss children from 1992 to 2001. Allergy. 2006;61(5):556-62.

Weber AS, Haidinger G. The prevalence of atopic dermatitis in children is influenced by their parents' education: results of two cross-sectional studies conducted in Upper Austria. Pediatr Allergy Immunol. 2010;21(7):1028-35. http://dx.doi: 10.1111/j.1399-3038.2010.01030.x.

Barnetson RS, Rogers M. Childhood atopic eczema. BMJ. 2002;324(7350):1376-9.

Gustafsson D, Sjöberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis--a prospective follow-up to 7 years of age. Allergy. 2000;55(3):240-5.

Fernández-Caldas E, Puerta L, Caraballo L. Mites and allergy. Chem Immunol Allergy. 2014;100:234-42. http://dx.doi: 10.1016/j.anai.2016.08.018.

Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361(9352):151-60.

Sánchez J, Páez B, Macías A, Olmos C, de Falco A. Atopic dermatitis guideline. Position paper from the Latin American Society of Allergy, Asthma and Immunology. Rev Alerg Mex. 2014;61(3):178-211.

de Bruin Weller MS, Rockmann H, Knulst AC, Bruijnzeel-Koomen CA. Evaluation of the adult patient with atopic dermatitis. Clin Exp Allergy. 2013;43(3):279-91. http://dx.doi: 10.1111/cea.12030.

Lapidus CS, Schwarz DF, Honig PJ. Atopic dermatitis in children: who cares? Who pays? J Am Acad Dermatol. 1993;28(5 Pt 1):699-703.

Kemp AS. Cost of illness of atopic dermatitis in children: a societal perspective. Pharmacoeconomics. 2003;21(2):105-13.

Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol. 1998;138(1):107-13.

DaVeiga SP. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc. 2012;33(3):227-34.

Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. 1999;103(1 Pt 1):125-38.

Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113(5):832-6.

Bieber T. Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine. Allergy. 2012;67(12):1475-82. http://dx.doi: 10.1111/all.12049.

Schram ME, Spuls PI, Leeflang MM, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy. 2012;67(1):99-106. http://dx.doi: 10.1111/j.1398-9995.2011.02719.x.

Hanifin JM. Diagnostic criteria for atopic dermatitis: consider the context. Arch Dermatol. 1999;135(12):1551.

Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005;352(22):2314-24.

Haas N, Martens F, Henz BM. Miliaria crystallina in an intensive care setting. Clin Exp Dermatol. 2004;29(1):32-4.

Thomas J, Peterson GM, Walton SF, Carson CF, Naunton M, Baby KE. Scabies: an ancient global disease with a need for new therapies. BMC Infect Dis. 2015;15:250. http://dx.doi: 10.1186/s12879-015-0983-z.

Heukelbach J, Wilcke T, Winter B, Feldmeier H. Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil. Br J Dermatol. 2005;153(1):150-6.

Karthikeyan K, Thappa DM, Jeevankumar B. Pattern of pediatric dermatoses in a referral center in South India. Indian Pediatr. 2004;41(4):373-7.

Bechelli LM, Haddad N, Pimenta WP, Pagnano PM, Melchior E, Fregnan RC, et al. Epidemiological survey of skin diseases in schoolchildren living in the Purus Valley (Acre State, Amazonia, Brazil). Dermatologica. 1981;163(1):78-93.

Inanir I, Sahin MT, Gündüz K, Dinç G, Türel A, Oztürkcan S. Prevalence of skin conditions in primary school children in Turkey: differences based on socioeconomic factors. Pediatr Dermatol. 2002;19(4):307-11.

Ogunbiyi AO, Owoaje E, Ndahi A. Prevalence of skin disorders in school children in Ibadan, Nigeria. Pediatr Dermatol. 2005;22(1):6-10.

Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995;8(3):483-91.

Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW, Committee IS. The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis. 2005;9(1):10-6.

Ninan TK, Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. BMJ. 1992;304(6831):873-5.

Ziyab AH, Raza A, Karmaus W, Tongue N, Zhang H, Matthews S, et al. Trends in eczema in the first 18 years of life: results from the Isle of Wight 1989 birth cohort study. Clin Exp Allergy. 2010;40(12):1776-84. http://dx.doi: 10.1111/j.1365-2222.2010.03633.x.

Farrokhi S, Gheybi MK, Movahhed A, Dehdari R, Gooya M, Keshvari S, et al. Prevalence and risk factors of asthma and allergic diseases in primary schoolchildren living in Bushehr, Iran: phase I, III ISAAC protocol. Iran J Allergy Asthma Immunol. 2014;13(5):348-55.

Farajzadeh S, Esfandiarpour I, Sedaghatmanesh M, Saviz M. Epidemiology and clinical features of atopic dermatitis in kerman, a desert area of iran. Ann Dermatol. 2014;26(1):26-34. http://dx.doi: 10.5021/ad.2014.26.1.26.

Craig-Müller SA, Reichenberg JS. The Other Itch That Rashes: a Clinical and Therapeutic Approach to Pruritus and Skin Picking Disorders. Curr Allergy Asthma Rep. 2015;15(6):532. http://dx.doi: 10.1007/s11882-015-0532-2.

Dennis R, Caraballo L, Garcia E, Caballero A, Aristizabal G, Cordoba H, et al. Asthma and other allergic conditions in Colombia: a study in 6 cities. Ann Allergy Asthma Immunol. 2004;93(6):568-74.

Dennis RJ, Caraballo L, García E, Rojas MX, Rondon MA, Pérez A, et al. Prevalence of asthma and other allergic conditions in Colombia 2009-2010: a cross-sectional study. BMC Pulm Med. 2012;12:17. http://dx.doi: 10.1186/1471-2466-12-17.

Dei-Cas I, Dei-Cas P, Acuña K. Atopic dermatitis and risk factors in poor children from Great Buenos Aires, Argentina. Clin Exp Dermatol. 2009;34(3):299-303.

Ricci G, Patrizi A, Baldi E, Menna G, Tabanelli M, Masi M. Long-term follow-up of atopic dermatitis: retrospective analysis of related risk factors and association with concomitant allergic diseases. J Am Acad Dermatol. 2006;55(5):765-71.

Illi S, von Mutius E, Lau S, Nickel R, Grüber C, Niggemann B, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004;113(5):925-31.

Chou JS, LeBovidge J, Timmons K, Elverson W, Morrill J, Schneider LC. Predictors of clinical success in a multidisciplinary model of atopic dermatitis treatment. Allergy Asthma Proc. 2011;32(5):377-83. http://dx.doi: 10.2500/aap.2011.32.3462.

Kidon MI, Chiang WC, Chin CW, Liew WK, Kang LW, Ong TC, et al. Mite component-specific IgE repertoire and phenotypes of allergic disease in childhood: the tropical perspective. Pediatr Allergy Immunol. 2011;22(2):202-10. http://dx.doi: 10.1111/j.1399-3038.2010.01094.x.

Williams HC, Burney PG, Pembroke AC, Hay RJ. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party. Br J Dermatol. 1996;135(1):12-7.

Popescu CM, Popescu R, Williams H, Forsea D. Community validation of the United Kingdom diagnostic criteria for atopic dermatitis in Romanian schoolchildren. Br J Dermatol. 1998;138(3):436-42.

Jøhnke H, Vach W, Norberg LA, Bindslev-Jensen C, Høst A, Andersen KE. A comparison between criteria for diagnosing atopic eczema in infants. Br J Dermatol. 2005;153(2):352-8.

Gruchalla RS, Gan V, Roy L, Bokovoy J, McDermott S, Lawrence G, et al. Results of an inner-city school-based asthma and allergy screening pilot study: a combined approach using written questionnaires and step testing. Ann Allergy Asthma Immunol. 2003;90(5):491-9.

Yamada E, Vanna AT, Naspitz CK, Solé D. International Study of Asthma and Allergies in Childhood (ISAAC): validation of the written questionnaire (eczema component) and prevalence of atopic eczema among Brazilian children. J Investig Allergol Clin Immunol. 2002;12(1):34-41.

Solé D, Mallol J, Wandalsen GF, Aguirre V, Group LAIPS. Prevalence of symptoms of eczema in Latin America: results of the International Study of Asthma and Allergies in Childhood (ISAAC) Phase 3. J Investig Allergol Clin Immunol. 2010;20(4):311-23.




DOI: http://dx.doi.org/10.29262/ram.v65i1.341

Enlaces refback

  • No hay ningún enlace refback.


Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.